Cargando…

A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application

Metabolic reprogramming is one of the characteristics of clear cell renal cell carcinoma (ccRCC). Although some treatments associated with the metabolic reprogramming for ccRCC have been identified, remain still lacking. In this study, we identified the differentially expressed genes (DEGs) associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qian, Ding, Lei, Zhou, Tianren, Zhai, Qidi, Ni, Chenbo, Liang, Chao, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513462/ https://www.ncbi.nlm.nih.gov/pubmed/36176391 http://dx.doi.org/10.3389/fonc.2022.982426

Ejemplares similares

Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma
por: Yang, Lin, et al.
Publicado: (2023)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma
por: Cheng, Xiangyu, et al.
Publicado: (2023)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Tan, Ying, et al.
Publicado: (2020)

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
por: Feng, Zhan, et al.
Publicado: (2020)

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
por: Li, Rong, et al.
Publicado: (2023)

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Cui, Yankang, et al.
Publicado: (2020)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
por: Tao, Junyue, et al.
Publicado: (2022)

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021)

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
por: Fan, Zongyao, et al.
Publicado: (2023)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
por: Lin, Dongxu, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
por: Garige, Mamatha, et al.
Publicado: (2022)

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
por: Wu, Xin, et al.
Publicado: (2023)

A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma
por: Pei, Dongchen, et al.
Publicado: (2022)

Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
por: Sun, Xiaomei, et al.
Publicado: (2023)

The Prognostic Value of Radiomics Features Extracted From Computed Tomography in Patients With Localized Clear Cell Renal Cell Carcinoma After Nephrectomy
por: Tang, Xin, et al.
Publicado: (2021)

Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022)

A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
por: Chen, Ji, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures
por: Tong, Ying, et al.
Publicado: (2021)

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
por: Qi, Xiaochen, et al.
Publicado: (2021)

Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients
por: Cui, Wanmeng, et al.
Publicado: (2019)

The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma
por: Mou, Yanhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_surmcbn62sd2c8erjml70durc9